title: Liquid chromatography mass spectrometric analysis of ouabainlike factor in biological fluid.
abstract: Ouabainlike factor (OLF), assayed as ouabainlike immunoreactivity (OLI), is a probable endogenous digitalislike factor (EDLF). Liquid chromatography/mass spectrometry (LC/MS) is one of the most highly sensitive tools for obtaining structural information regarding low-molecular weight materials in a target compound, and to measure the concentrations of these materials. We have previously reported that OLI can be isolated from the culture supernatant of the rat pheochromocytoma cell line, PC12, by several reverse-phase chromatography and LC/MS techniques. The present study was performed to characterize OLF from biological fluids such as plasma and culture supernatant of PC12 cells by LC/MS. The previous applications of LC/MS to OLI in plasma have been limited to structural identification at the final stages of isolation, in which the starting volume of plasma has been over 10 I. In the present study, we tried to minimize the volume of plasma, and to develop a new preclearing step to gain adequate LC/MS characterization using MS/MS analysis. The plasma was acidified, and OLI was purified by ODS column chromatography. OLI in chromatographic fractions from plasma was assayed by a sensitive enzyme-linked immunosorbent assay for ouabain. After Sep-Pak treatment and two rounds of ODS column chromatography, OLI was identified from 80 ml of plasma. The structure of the purified OLI was identical to authentic ouabain and digoxin, as assessed by LC/MS. In conclusion, we identified the chemically or structurally clarified ouabain and digoxin as the circulating form in plasma by LC/MS.
authors.affiliation: Department of Clinical Sciences and Laboratory Medicine, Kansai Medical University, Moriguchi, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Komiyama
authors.forename: N
authors.initials: N
authors.lastname: Nishimura
authors.forename: X H
authors.initials: XH
authors.lastname: Dong
authors.forename: S
authors.initials: S
authors.lastname: Hirose
authors.forename: C
authors.initials: C
authors.lastname: Kosaka
authors.forename: H
authors.initials: H
authors.lastname: Masaki
authors.forename: M
authors.initials: M
authors.lastname: Masuda
authors.forename: H
authors.initials: H
authors.lastname: Takahashi
mesh_terms: D000818:Animals; D002298:Cardenolides; D002316:Cardiotonic Agents / Q000032:analysis; D002853:Chromatography, Liquid; D004077:Digoxin; D006801:Humans; D006973:Hypertension / Q000097:blood*; D013058:Mass Spectrometry; D010042:Ouabain / Q000032:analysis; D016716:PC12 Cells; D051381:Rats; D012503:Saponins / Q000032:analysis* / Q000097:blood*
chemical_list: D002298:Cardenolides; D002316:Cardiotonic Agents; D012503:Saponins; C034504:digoxin-like factors; D010042:Ouabain; D004077:Digoxin